ShareValue scores for WNX.LSE: Valuation 67, Quality 8, Growth 50, Health 45.

WNX.LSE
LSE

Wellnex Life Limited

£0.06(+69.23%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

5% to 19%
Valuation
67
Fair Value
Price vs Value
Quality
8
Weak
Business Strength
Growth
50
Moderate
Revenue & Earnings
Health
45
Moderate
Financial Stability
Momentum
12
Bearish
Price Trend

Company Details

About

Wellnex Life Limited, together with its subsidiaries, develops, markets, and sells health and wellness products in Australia, New Zealand, and the United Kingdom. The company offers topical anti-inflammatory creams, sprays, and roll-ons under the Pain Away brand; caffeine energy liquid capsules and multivitamins under the Wakey Wakey brand; sleep aid products under the Nighty Night brand; teeth whitening solutions under the Mr. Bright brand; pain relief capsules under the Wagner Liquigesics brand; medicinal cannabis under the Wellness Life brand; and over-the-counter medicines under the Pharmacy Own brand. It is also involved in the holding of intellectual properties and trademarks of its products; brand and pharma solution businesses; and investment activities. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Port Melbourne, Australia.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026